LOJECLY

Trademark usage description

pharmaceuticals and medical preparations and substances and vaccines for the prevention and treatment of disorders and diseases in, generated by or ac Read More

Classification Information

Class [005]
Pharmaceuticals and medical preparations and substances and vaccines for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system, namely, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls due to loss of balance, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and alcohol dependency; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system, namely dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls due to loss of balance, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and alcohol dependency; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases, namely dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls due to loss of balance, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and alcohol dependency; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls due to loss of balance, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and alcohol dependency; diagnostic reagents and agents for medical diagnostic use.

Classification kind code

Class [009]
Integrated medical systems containing dosage dispensers and software for accessing information and information management in the fields of neurology, neurological diseases and disorders, and brain diseases and disorders for use in Web-based physical, psychological, and neurological examination and assessment of patients and clients remotely and at a clinic; surgical and medical apparatus and instruments, namely, dosage dispensers.

Classification kind code

Class [010]
Surgical and medical apparatus and instruments, namely, knives for surgical use, lasers for surgical or medical use, medical and surgical catheters, medical and surgical laparoscopes, surgical clamps, surgical drills, surgical instruments, dispensers, namely, aerosol dispensers for medical purposes; syringes and needles for injections and medical purposes; test kits comprising medical instruments for general examination for testing neurological diseases, namely, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls due to loss of balance, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and alcohol dependency, medical instruments for general examination; integrated medical systems containing medical instruments, namely, drainage tubes, electrodes, incubators, injection needles, irrigators, guide wires, respirators, dispensers, namely, aerosol dispensers for medical purposes, needles for injections, and syringes for medical purposes for use in Web-based physical and psychological and neurological examination and assessment of patients and clients remotely and at a clinic; medical instruments for information, guidance, management and control of medicines, namely, drainage tubes, electrodes, incubators, injection needles, irrigators, guide wires, respirators, dispensers, namely, aerosol dispensers for medical purposes.

Classification kind code

Mark Details

Serial Number

1882439

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 42 on 19^th Aug 2020	Advertised
Submitted for opposition 26 on 23^rd Jul 2020	Approved
Submitted for opposition 27 on 23^rd Jul 2020	Approval Notice Sent
Submitted for opposition 15 on 7^th Oct 2019	Correspondence Created
Submitted for opposition 67 on 11^th Sept 2019	Agent Name Changed
Submitted for opposition 22 on 7^th May 2019	Search Recorded
Submitted for opposition 20 on 7^th May 2019	Examiner's First Report
Submitted for opposition 31 on 14^th Feb 2018	Formalized
Submitted for opposition 1 on 12^th Feb 2018	Created
Submitted for opposition 30 on 9^th Feb 2018	Filed